Literature DB >> 8619417

Successful treatment of acute promyelocytic leukemia in a pregnant Jehovah's Witness with all-trans retinoic acid, rhG-CSF, and erythropoietin.

C P Lin, M J Huang, H J Liu, I Y Chang, C H Tsai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8619417     DOI： 10.1002/(SICI)1096-8652(199603)51:3<251::AID-AJH20>3.0.CO;2-I

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  5 in total

Review 1.  Acute promyelocytic leukemia during pregnancy: report of 3 cases.

Authors:  Ugo Consoli; Amalia Figuera; Giuseppe Milone; Carmela Rita Meli; Giulia Guido; Francesco Indelicato; Gaetano Moschetti; Salvatore Leotta; Antonella Tornello; Massimo Poidomani; Pamela Murgano; Valeria Pinto; Rosario Giustolisi
Journal:  Int J Hematol       Date:  2004-01       Impact factor: 2.490

2.  Complete remission induced by gemtuzumab ozogamicin in a Jehovah's Witness patient with acute myelogenous leukemia.

Authors:  Shinya Fujisawa; Kensuke Naito; Toshihiko Matsuoka; Masahide Kobayashi
Journal:  Int J Hematol       Date:  2007-06       Impact factor: 2.490

Review 3.  Gynecologic malignancy in pregnancy.

Authors:  Yong Il Ji; Ki Tae Kim
Journal:  Obstet Gynecol Sci       Date:  2013-09-14

4.  Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation.

Authors:  Anand P Jillella; Martha L Arellano; Leonard T Heffner; Manila Gaddh; Amelia A Langston; Hanna J Khoury; Abhishek Mangoankar; Vamsi K Kota
Journal:  Hematol Rep       Date:  2017-09-26

5.  Acute Promyelocytic Leukemia during Pregnancy: A Systematic Review of the Literature.

Authors:  Andrea Santolaria; Alfredo Perales; Pau Montesinos; Miguel A Sanz
Journal:  Cancers (Basel)       Date:  2020-04-14       Impact factor: 6.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.